World Library  
Flag as Inappropriate
Email this Article

Mucolipidosis type IV

Article Id: WHEBN0005881304
Reproduction Date:

Title: Mucolipidosis type IV  
Author: World Heritage Encyclopedia
Language: English
Subject: Channelopathy, Lysosomal storage diseases, Mucolipidosis, Ashkenazi Jews topics, Dor Yeshorim
Collection: Ashkenazi Jews Topics, Autosomal Recessive Disorders, Channelopathy, Lysosomal Storage Diseases
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Mucolipidosis type IV

Mucolipidosis type IV
Classification and external resources
ICD-10 E75.1
OMIM 252650
DiseasesDB 32693
MeSH D009081
GeneReviews
  • Mucolipidosis IV

Mucolipidosis type IV (ML IV or ML4) is an autosomal recessive lysosomal storage disorder. Individuals with the disorder have many symptoms including delayed psychomotor development and various ocular aberrations. The disorder is caused by mutations in the MCOLN1 gene, which encodes a non-selective cation channel, mucolipin1.[1][2] These mutations disrupt cellular functions and lead to a neurodevelopmental disorder through an unknown mechanism. Researchers dispute the physiological role of the protein product and which ion it transports.[3]

Contents

  • Symptoms and Signs 1
  • Pathophysiology 2
  • Treatment/Management 3
  • Epidemiology 4
  • References 5
  • External links 6

Symptoms and Signs

Most patients with ML IV show psychomotor retardation (i.e., delayed development of movement and coordination), corneal opacity, retinal degeneration and other ophthalmological abnormalities. Other symptoms include agenesis of the corpus callosum, iron deficiency resulting from an absence of acid secretion in the stomach, achlorhydria. Achlorhydria in these patients results in an increase in blood gastrin levels. These symptoms typically manifest early in life (within the first year). After disease onset there occurs a period of stability, typically lasting two to three decades during which very little disease progression occurs.[4]

Pathophysiology

Mucolipidosis type IV has an autosomal recessive pattern of inheritance.

Mucolipin1 is thought to be localized in endosomes. An important property of mucolipin1 is that decreasing pH (acidification) results in deactivation of the protein, likely through an assembly defect. There are at least 29 known mutations in MCOLN1, located throughout the gene.[5] Many of the known mutations result in no expression of mucolipin1. Milder mutations, such as ΔF408 and V446L, produce a dysfunctioning form of the cation channel.[6] Mutations that alter only the C-terminal of the protein also result in a mild phenotype of the disorder, usually sparing the brain.[7] ML IV causes affected cells to accumulate auto-fluorescent vacuoles considered to be aberrant lysosomes.[8] Several evidences exist for a defect in both exocytosis and endocytosis.[9] There are conflicting indications of abnormal lysosomal pH in MLIV. It is not yet clear why these abnormalities will cause incomplete development of the brain, achlorhydria, and failure in the maintenance of retinal tissue.

Treatment/Management

There is no specific treatment to this disorder. However, several symptoms may be alleviated. For instance, anemia is treated by iron supplements. Some of the movement deficiencies may be corrected with orthopedic intervention. The corneal clouding can be, at least, temporarily corrected by corneal transplantation. See the equivalent section in the main mucolipidosis article.

Epidemiology

Mucolipidosis type IV is severely under-diagnosed. It is often misdiagnosed as cerebral palsy. In the Ashkenazi Jewish population there are two severe mutations with a higher carrier frequency[10] of 1:90 to 1:100.[11]

References

  1. ^ Nilius, B.; Owsianik, G.; Voets, T.; Peters, J. A. (2007). "Transient Receptor Potential Cation Channels in Disease". Physiological Reviews 87 (1): 165–217.  
  2. ^ Sun, M.; Goldin, E; Stahl, S; Falardeau, J. L.; Kennedy, J. C.; Acierno Jr, J. S.; Bove, C; Kaneski, C. R.; Nagle, J; Bromley, M. C.; Colman, M; Schiffmann, R; Slaugenhaupt, S. A. (2000). "Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel". Human Molecular Genetics 9 (17): 2471–8.  
  3. ^ Dong, Xian-Ping; Cheng, Xiping; Mills, Eric; Delling, Markus; Wang, Fudi; Kurz, Tino; Xu, Haoxing (2008). "The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel". Nature 455 (7215): 992.  
  4. ^ Wakabayashi, K.; Gustafson, A. M.; Sidransky, E.; Goldin, E. (2011). "Mucolipidosis type IV: An update". Molecular Genetics and Metabolism 104 (3): 206–213.  
  5. ^ Goldin E, Slaugenhaupt SA, Smith J, Schiffmann R (2005) Mucolipidosis IV, GeneReviews at GeneTests: Medical Genetics Information Resource http://www.ncbi.nlm.nih.gov/books/NBK1214/
  6. ^ Altarescu, G.; Sun, M.; Moore, D. F.; Smith, J. A.; Wiggs, E. A.; Solomon, B. I.; Patronas, N. J.; Frei, K. P.; Gupta, S.; Kaneski, C. R.; Quarrell, O. W.; Slaugenhaupt, S. A.; Goldin, E.; Schiffmann, R. (2002). "The neurogenetics of mucolipidosis type IV". Neurology 59 (3): 306.  
  7. ^ Goldin, E.; Caruso, R. C.; Benko, W.; Kaneski, C. R.; Stahl, S.; Schiffmann, R. (2008). "Isolated Ocular Disease is Associated with Decreased Mucolipin-1 Channel Conductance". Investigative Ophthalmology & Visual Science 49 (7): 3134.  
  8. ^ Goldin, Ehud; Blanchette-Mackie, E Joan; Dwyer, Nancy K; Pentchev, Peter G; Brady, Roscoe O (1995). "Cultured Skin Fibroblasts Derived from Patients with Mucolipidosis 4 Are Auto-Fluorescent". Pediatric Research 37 (6): 687.  
  9. ^ Chen, C. S.; Bach, G; Pagano, R. E. (1998). "Abnormal transport along the lysosomal pathway in Mucolipidosis, type IV disease". Proceedings of the National Academy of Sciences of the United States of America 95 (11): 6373–6378.  
  10. ^ Bach, Gideon; Webb, Michael B.T.; Bargal, Ruth; Zeigler, Marcia; Ekstein, Joseph (2005). "The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations". Human Mutation 26 (6): 591.  
  11. ^ Bargal, Ruth; Avidan, Nili; Olender, Tzvia; Ben Asher, Edna; Zeigler, Marcia; Raas-Rothschild, Annick; Frumkin, Ayala; Ben-Yoseph, Omer; Friedlender, Yechiel; Lancet, Doron; Bach, Gideon (2001). "Mucolipidosis type IV: NovelMCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population". Human Mutation 17 (5): 397.  

External links

  • Mucolipidosis type 4 at NIH's Office of Rare Diseases
  • Mucolipidosis IV Foundation
  • Gene Test Diagnostic Organization
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.